Enliven Therapeutics 2025 financial results is transforming the industry. When Enliven Therapeutics dropped its 2025 financial results last week, the biotech sector took notice-not just for the numbers, but for the audacious precision behind them. I’ve pored over enough quarterly filings to recognize when a company doesn’t just survive its own hype; when it outmaneuvers […]